Connect with us

COVID-19 WATCH

FDA approves emergency use of Moderna vax on adolescents aged 12 to 17

Published

on

The country’s Food and Drug Administration (FDA) on Friday approved the emergency use authorization of Moderna Covid-19 vaccine on adolescents aged 12 to 17.

“After a thorough evaluation by our vaccine experts and our regulatory experts in FDA, we approved this Friday the use under EUA of the Moderna vaccine for adolescents aged 12 to 17,” FDA Director General Eric Domingo said in the Laging Handa public briefing.

Domingo said the presence of the highly transmissible Delta variant prompted the agency to amend the EUA of Moderna, which filed the application to its EAU amendment on 19 August.

“With the Delta variant affecting a lot of children, the experts see that the benefits of the vaccine outweigh the risks,” he added.

However, the FDA chief warned of rare adverse effects such as myocarditis, which may develop in individuals who received Moderna and other mRNA vaccines like Pfizer.

Domingo said myocarditis is very rare as the ratio for this adverse effect can be one in every million. He also added

Advertisement

LIKE US ON FACEBOOK

Advertisement
Advertisement